Dietary restriction rescues 5-fluorouracil-induced lethal intestinal toxicity in old mice by blocking translocation of opportunistic pathogens

被引:3
|
作者
Tang, Duozhuang [1 ,2 ]
Qiu, Rongrong [1 ]
Qiu, Xingxing [1 ]
Sun, Man [1 ]
Su, Mingyue [1 ]
Tao, Zhendong [3 ]
Zhang, Liu [4 ]
Tao, Si [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Dept Oncol, Jiangxi Key Lab Clin & Translat Canc Res, Min De Rd 1, Nanchang 330006, Jiangxi, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 2, Dept Hematol, Nanchang, Jiangxi, Peoples R China
[3] Jiangxi Prov Hosp Integrated Chinese & Western Med, Dept Med Lab Med, Nanchang, Jiangxi, Peoples R China
[4] Capital Med Univ, Beijing Jishuitan Hosp, Intens Care Unit, Beijing, Peoples R China
关键词
Dietary restriction; chemotherapy; aging; intestinal toxicity; gut microbiota; DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; MICROBIOTA; CELLS; INFLAMMATION; CHEMOTHERAPY; DYSBIOSIS; AGE; IDENTIFICATION; DERIVATIVES;
D O I
10.1080/19490976.2024.2355693
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chemotherapy remains a major treatment for malignant tumors, yet the application of standard dose intensity chemotherapy is limited due to the side effects of cytotoxic drugs, especially in old populations. The underlying mechanisms of cytotoxicity and strategies to increase the safety and tolerance of chemotherapy remain to be explored. Using 5-fluorouracil (5-FU), a cornerstone chemotherapeutic drug, we demonstrate that the main cause of death in ad libitum (AL) fed mice after 5-FU chemotherapy was infection caused by translocation of intestinal opportunistic pathogens. We show that these opportunistic pathogens greatly increase in the intestine after chemotherapy, which was closely related to loss of intestinal lysozyme. Of note, two weeks of dietary restriction (DR) prior to chemotherapy significantly protected the loss of lysozyme and increased the content of the beneficial Lactobacillus genera, resulting in a substantial inhibition of intestinal opportunistic pathogens and their translocation. The rescue effect of DR could be mimicked by Lysozyme or Lactobacillus gavage. Our study provides the first evidence that DR achieved a comprehensive protection of the intestinal physical, biological and chemical barriers, which significantly improved the overall survival of 5-FU-treated mice. Importantly, the above findings were more prominent in old mice. Furthermore, we show that patients over 65 years old have enriched opportunistic pathogens in their gut microbiota, especially after 5-FU based chemotherapy. Our study reveals important mechanisms for the poor chemotherapy tolerance of the elderly population, which can be significantly improved by short-term DR. This study generates new insights into methods for improving the chemotherapeutic prognosis by increasing the chemotherapy tolerance and safety of patients with malignant tumors.
引用
收藏
页数:29
相关论文
共 50 条
  • [1] Probiotic Bifidobacterium prevents 5-fluorouracil-induced intestinal mucositis in mice
    Izumi, Yuichiro
    Tominaga, Ai
    Arakawa, Maho
    Miyamoto, Asuka
    Matsumoto, Kenjiro
    Amagase, Kikuko
    Kato, Shinichi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S173 - S173
  • [2] Puerarin Ameliorates 5-Fluorouracil-Induced Intestinal Mucositis in Mice by Inhibiting JAKs
    Wang, Liang
    Song, Baohui
    Hu, Yan
    Chen, Jun
    Zhang, Shuaishuai
    Chen, Dapeng
    Wang, Jingyu
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2021, 379 (02): : 147 - 155
  • [3] Pathogenic Role of Dysbiosis in the Development of 5-Fluorouracil-Induced Intestinal Mucositis in Mice
    Hamouda, Nahla
    Sano, Tetsushi
    Shimakawa, Masaki
    Matsumoto, Kenjiro
    Amagase, Kikuko
    Higuchi, Kazuhide
    Kato, Shinichi
    DIGESTION, 2019, 99 (01) : 110 - 110
  • [4] Protective Effects of Oxyberberine in 5-Fluorouracil-Induced Intestinal Mucositis in the Mice Model
    Huang, Ronglei
    Ai, Gaoxiang
    Zhong, Linjiang
    Mai, Liting
    Chen, Jian-Nan
    Liu, Yuhong
    Li, Yucui
    Huang, Xiaoqi
    Su, Ziren
    Zhan, Janis Ya-Xian
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [5] 5-Fluorouracil-induced intestinal toxicity: what determines the severity of damage to murine intestinal crypt epithelia?
    Inomata, A
    Horii, I
    Suzuki, K
    TOXICOLOGY LETTERS, 2002, 133 (2-3) : 231 - 240
  • [6] Optimization of a 5-Fluorouracil-induced intestinal injury model in mice to construct a multi-scale predictive model of drug-induced intestinal toxicity
    Jardi, F.
    Van Heerden, M.
    Vereyken, L.
    Erkens, T.
    Rodrigues, D. F.
    Kleinjans, J. C. S.
    de Kok, T. M.
    Ferreria, S.
    Gardner, I.
    Fisher, C.
    Pritchard, M.
    Lynch, A.
    Sevin, D.
    Beattie, K.
    Pin, C.
    Lammens, L.
    de Jonghe, S.
    TOXICOLOGY LETTERS, 2019, 314 : S73 - S74
  • [7] Mucoprotective effects of Saikosaponin-A in 5-fluorouracil-induced intestinal mucositis in mice model
    Ali, Jawad
    Khan, Ashraf Ullah
    Shah, Fawad Ali
    Ali, Hussain
    Ul Islam, Salman
    Kim, Yeong Shik
    Khan, Salman
    LIFE SCIENCES, 2019, 239
  • [8] Berberine Alleviates 5-Fluorouracil-Induced Inflammatory Response in Macrophages and Intestinal Mucositis in Mice
    Chen, Shu
    Xi, Yue
    Zhang, Hai
    Xu, Sanrong
    Chen, Shengzhi
    Yang, Zhengnan
    Wu, Liang
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2024, 38 (01): : 263 - 275
  • [9] Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice
    Pedro M. G. Soares
    Roberto C. P. Lima-Junior
    José Maurício S. C. Mota
    Priscilla F. C. Justino
    Gerly Anne C. Brito
    Ronaldo A. Ribeiro
    Fernando Q. Cunha
    Marcellus H. L. P. Souza
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 713 - 720
  • [10] Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice
    Soares, Pedro M. G.
    Lima-Junior, Roberto C. P.
    Mota, Jose Mauricio S. C.
    Justino, Priscilla F. C.
    Brito, Gerly Anne C.
    Ribeiro, Ronaldo A.
    Cunha, Fernando Q.
    Souza, Marcellus H. L. P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 713 - 720